European Harm Reduction Conference 2024

By Ana Balkandjieva

10 February 2024

Harm reduction

From 2 to 4 December

The 6th European Harm Reduction Conference (EHRC2024) will take place in Warsaw, Poland from 2 to 4 December 2024. It is organized by the Correlation – European Harm Reduction Network (C-EHRN).

The conference presented the latest harm reduction research results, innovative and next best-thing practices while discussing drug policy including the need to scale up harm reduction services. It provides an appropriate platform to create a link between national and European developments in drug policies and harm reduction.

Visit the EHRC2024 website.

Related materials

HCV Market Intelligence Report 2023

CHAI releases the third issue of the HCV Market Intelligence Report on HCV diagnostics and drugs in LMICs, including for the first time preliminary insights into harm reduction commodities. More

27 January 2024Advocate Advocacy Tools

Global State of Harm Reduction: 2023 Update to Key Data

The 2023 update summarises some of the key developments in harm reduction and drug policy since the launch of the 8th edition of the Global State of Harm Reduction report in November 2022. More

27 January 2024Advocate Advocacy Tools

Joint Report on Drug Consumption Rooms in Europe

A report, released by EMCDDA and C-EHRN, presents the latest overview on drug consumption rooms in Europe. More

27 January 2024Advocate Advocacy Tools

Inspiring Short Film on Ireland’s Health Led Approach to Drugs Use

Watch Drugreporter’s video on Ireland’s innovative harm reduction tradition, and the country’s steps towards decriminalisation. More

27 January 2024Learn Care

Report Launch: The Mental Health Challenges Faced by Harm Reduction Staff

Webinar, organized by the Correlation – European Harm Reduction Network, to mark the publication of the report. More

6 February 2024News Calendar

Eliminating Hepatitis C in Europe: Report on Policy Implementation for People Who Inject Drugs

C-EHRN releases a report focusing on the availability of and access to interventions that constitute the HCV continuum of care specific for people who inject drugs in 35 European cities. More

6 February 2024Advocate Advocacy Tools

The Amsterdam Manifesto: A Catalyst for Change in Drug Policy

A diverse coalition of policymakers, scientists and civil society representatives unite in creating more humane drug policy by prioritizing the well-being of all impacted by the multifaceted challenges of illegal drug markets. Endorse NOW! More

10 February 2024Advocate Take Action!

Telemedicine at Syringe Access Programs May Address Barriers, Expand Access to HCV Treatment

A survey found telemedicine-based HCV treatment at a syringe access program could improve access to treatment among people who inject drugs. More

28 March 2024Learn Treatment

JAMA Paper: In People with Opioid Use Disorder, Telemedicine Treatment for HCV Was More Than Twice as Successful as Off-Site Referral

The study is one of only a few randomized controlled trials that have been conducted to determine the effectiveness of using telemedicine to improve health care access for vulnerable populations. More

11 April 2024Learn Treatment

UNAIDS Welcomes the Adoption of a Crucial Resolution Recognizing Harm Reduction Measures at the UN Commission on Narcotic Drugs

UNAIDS welcomes the adoption of a key resolution at the 67th session of the United Nations Commission on Narcotic Drugs, recognizing harm reduction for the first time as an important part of an effective public health response. More

11 April 2024Advocate Policy Statements